Compare Amgen, Inc. (AMGN) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amgen, Inc. vs Nano Dimension Ltd - ADR — how do they compare? Amgen, Inc. trades at $360.83 (market cap $196.12B), while Nano Dimension Ltd - ADR trades at $1.49 (market cap $314.71M). The key difference: Amgen, Inc. is far larger — about 623.2× Nano Dimension Ltd - ADR's market cap, and Amgen, Inc. pays a 2.77% dividend while Nano Dimension Ltd - ADR pays none. Which is the better fit depends on your goals.
| AMGN | NNDM | |
|---|---|---|
Market Cap | $196.12B | $314.71M |
Sector | Health | Technology |
52-Week High | $388.16 | $2.14 |
52-Week Low | $271.18 | $1.21 |
Enterprise Value | $241.41B | -$94.63M |
Dividend Yield | 2.77% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amgen, Inc.
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Read more on AMGN →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
